Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction

Front Genet. 2023 Jun 8:14:1180076. doi: 10.3389/fgene.2023.1180076. eCollection 2023.

¹ Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
² Department of Medical Oncology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
³ Department of Pharmacy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
⁴ Department of Gastroenterology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.

Abstract

[This corrects the article DOI: 10.3389/fgene.2022.1092678.].

Keywords: DLBCL; TMEM63A; microtube-associated genes; prognostic model; targeting therapy.